EIR Altaire Pharmaceuticals Nov 2010

Robert Horan FDA, Edmund Mrak FDA$595.00 - Available Now

FDA investigators audited the Altaire Pharmaceuticals - Aquebogue, NY, United States facility and issued inspectional observation (via FDA 483) on 19 Nov 2010.

Product details

  • Category:
  • Inspection end: 19 Nov 2010
  • Location: Aquebogue, United States
  • FEI: 1000119582
Add To Cart